Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
A new partnership between Aledade and Anthem Blue Cross and Blue Shield in Virginia aims to improve access to value-based primary care for Medicaid members.
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
Aledade's $260 million financing round was led by Lightspeed Venture Partners, a new investor of the company. It also included participation from Venrock, Avidity Partners, OMERS Growth Equity and Fidelity Management and Research Company.
CareFirst's in-network practices will have access to support from Aledade’s specialists. This includes on-site coaching and regulatory and policy expertise. In addition, they’ll have access to Aledade’s population health management platform, which is integrated with more than 100 electronic health records.
Aledade — an independent primary care network focused on value-based care — struck a 10-year partnership with insurer Humana. Under the collaboration, Humana’s Medicare Advantage members will receive primary care from Aledade physicians using value-based arrangements.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
By adding 450 primary care practices to its network, the company claims to be the largest network of independent primary care. In total, the company now works with more than 1,500 independent primary care practices and health centers and has more than 150 value-based contracts across Medicare, Medicare Advantage, Medicaid and commercial plans.
Pearl Health — a technology company that helps independent physician practices participate in value-based care models — just raised $75 million in Series B financing. Pearl’s platform leverages data science to help primary care providers focus on patients who are driving expenses and need care the most.
Aledade said that its value-based care network has helped save the U.S. healthcare system save more than $1.2 billion over the past eight years. A primary care physician at an accountable care organization that works with Aledade testified that being a part of the network has yielded significant shared savings that have led to better care outcomes, such as lower re-hospitalization rates.
Aledade, a startup that partners with independent practices to establish accountable care organizations, raised $123 million in a Series E funding round. The company plans to use the money to advance its partnerships with Medicare Advantage plans and add solutions to its new healthcare services subsidiary.
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.
In a virtual panel discussion about public and population health at J.P. Morgan's annual conference, the CEO of Aledade shared how the quest for efficiency in a world of harried physicians' practices almost led Aledade to use a flawed ML algorithm to engage at-risk patients of those practices.
The company partners with independent practices, health centers and clinics to establish primary care-focused accountable care organizations.
This week, check out news from healthcare startups including Spry Health, Heal Co, and more.
Aledade, a health IT company founded by former national health IT coordinator Dr. Farzad Mostashari, raised $64 million in funding. Aledade operates ACOs with more than 550 independent physician practices.
UnitedHealthGroup's OptumCare subsidiary is acquiring Surgical Care Affiliates for $2.3 billion, Takeda is ponying up $5.2 billion to acquire Ariad Pharmaceuticals, while Aledade closed on a $20 million funding round.